Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
Aleksandrova K, Boeing H, Nöthlings U, Jenab M, Fedirko V, Kaaks R, Lukanova A, Trichopoulou A, Trichopoulos D, Boffetta P, Trepo E, Westhpal S, Duarte-Salles T, Stepien M, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC, Dossus L, Racine A, Lagiou P, Bamia C, Benetou V, Agnoli C, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita B, Peeters PH, Gram IT, Lund E, Weiderpass E, Quirós JR, Agudo A, Sánchez MJ, Gavrila D, Barricarte A, Dorronsoro M, Ohlsson B, Lindkvist B, Johansson A, Sund M, Khaw KT, Wareham N, Travis RC, Riboli E, Pischon T.
Aleksandrova K, et al. Among authors: trepo e.
Hepatology. 2014 Sep;60(3):858-71. doi: 10.1002/hep.27016. Epub 2014 Jul 29.
Hepatology. 2014.
PMID: 24443059
Free PMC article.
Clinical Trial.